Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Mitchell Mathis, MD
JCP
Review Article
Placebo and Treatment Effects in Schizophrenia Trials
March 3, 2020
Efficacy trials in schizophrenia patients conducted from 1991 to 2009 showed an increasing rate of placebo response and a decline in treatment effect over time. This study explores these...
Mathangi Gopalakrishnan
,
Hao Zhu
,
Tiffany R. Farchione
, et al
JCP
Review Article
Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration
March 15, 2014
Silvana Borges
,
Yeh-Fong Chen
,
Thomas P. Laughren
, et al
JCP
Original Research
CYP2D6 Genotype Information to Guide Pimozide Treatment in Adult and Pediatric Patients: Basis for the US Food and Drug Administration's New Dosing Recommendations
September 15, 2012
Hobart L. Rogers
,
Atul Bhattaram
,
Issam Zineh
, et al
JCP
Original Research
Vilazodone: Clinical Basis for the US Food and Drug Administration's Approval of a New Antidepressant
September 15, 2011
Thomas P. Laughren
,
Jogarao Gobburu
,
Robert J. Temple
, et al
